Table 1.
Positive test results | |||||
---|---|---|---|---|---|
Numbers analysed | Peak month | Amplitude (%) | Crude 95% CI* | Edwards’ & Roger’s P | |
All tests |
|
||||
0-14 |
1150 |
March |
31.3 |
31.0-31.5 |
<0.0001 |
15-24 |
6119 |
February |
14.3 |
14.2-14.3 |
<0.0001 |
25-44 |
1156 |
March |
1.9 |
1.7-2.1 |
0.9 |
>45 |
222 |
August |
18.3 |
17.0-19.6 |
0.3 |
All ages |
8647 |
February |
13.8 |
13.8-14 |
<0.0001 |
Female |
|
||||
0-14 |
691 |
March |
32.4 |
32.0-32.8 |
<0.0001 |
15-24 |
3300 |
February |
16.2 |
16.1-16.3 |
<0.0001 |
25-44 |
554 |
February |
8.1 |
7.6-8.6 |
0.1 |
>45 |
101 |
April |
29.1 |
26.3-31.8 |
0.3 |
All ages |
4646 |
February |
16.6 |
16.6-17.0 |
<0.0001 |
Male |
|
||||
0-14 |
459 |
March |
29.9 |
29.3-30.5 |
<0.0001 |
15-24 |
2819 |
February |
11.9 |
11.8-12.0 |
<0.0001 |
25-44 |
602 |
July |
4.4 |
3.9-4.9 |
0.6 |
>45 |
121 |
August |
20.3 |
18.1-22.7 |
0.2 |
All ages |
4001 |
February |
10.5 |
10.5-10.6 |
<0.0001 |
Total tests performed | |||||
|
Numbers analysed |
Peak month |
Amplitude (%) |
Crude 95% CI* |
Edwards’ & Roger’s P |
All tests |
|
||||
0-14 |
9884 |
February |
34.5 |
34.4-34.5 |
<0.0001 |
15-24 |
30663 |
February |
12.2 |
12.2-12.2 |
<0.0001 |
25-44 |
17615 |
April |
12.9 |
12.9-12.9 |
<0.0001 |
>45 |
4066 |
March |
13.0 |
12.9-13.1 |
<0.0001 |
All ages |
62228 |
February |
13.8 |
13.8-13.8 |
<0.0001 |
Female |
|
||||
0-14 |
5565 |
February |
32.1 |
32.0-32.2 |
<0.0001 |
15-24 |
18873 |
February |
13.1 |
13.1-13.1 |
<0.0001 |
25-44 |
10936 |
March |
16.6 |
16.5-16.6 |
<0.0001 |
>45 |
2449 |
March |
17.0 |
16.9-17.1 |
<0.0001 |
All ages |
37823 |
February |
14.4 |
14.4-14.4 |
<0.0001 |
Male |
|
||||
0-14 |
4319 |
February |
37.6 |
37.5-37.7 |
<0.0001 |
15-24 |
11790 |
February |
10.8 |
10.8-10.9 |
<0.0001 |
25-44 |
6679 |
April |
6.9 |
6.9-7.0 |
0.009 |
>45 |
1617 |
March |
7.5 |
7.4-7.7 |
0.1 |
All ages | 24405 | February | 12.8 | 12.8-12.9 | <0.0001 |
*CI: 95% Confidence intervals.